Actualités sur Savoir / Culture
- plus
Debiopharm International SA Awarded $2.6 Million Grant from CARB-X to Support Development of Debio 1453 to fight drug resistant gonorrhea
Lausanne (ots) - Debiopharm, in collaboration with CARB-X, will utilize their state-of-the-art Fabiotics platform to develop novel therapeutics to combat drug-resistant gonorrhea. Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical ...
plusSequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study for the alfapump® vs. Large Volume Paracentesis for Refractory Ascites in Journal of Hepatology
Zurich (ots) - Sequana Medical AG ("Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of a multicentre, randomized controlled trial in the Journal of Hepatology (http://ots.ch/w2er5). The study demonstrated that in patients with ...
plusLong-term outcomes after standard graft-versus-host disease (GvHD) prophylaxis in hemopoietic cell transplantation from matched unrelated donors strongly support the use of Grafalon® as standard therapy
plusImmunoQure AG announces publication in Cell of naturally occurring patient-derived autoantibodies that limit human diseases
Düsseldorf (ots) - ImmunoQure AG, a German biotechnology company focused on the development of autoantibodies as therapeutics to treat common human diseases today announced the publication of data in the leading scientific journal Cell, demonstrating that such therapeutics can limit a variety of common human ...
plusTRON - Translational Oncology at University Medical Center Mainz
First preclinical proof-of-concept of mutation-based individualized cancer vaccine / Deep sequencing of immunogenic mutations may pave way for customized immunotherapy
Mainz (ots) - The Institute of Translational Oncology (TRON) together with BioNTech AG today announced the publication of a joint paper in the international journal Cancer Research that describes a new path for individually tailored cancer therapy. An interdisciplinary team of genome scientists and immunologists led ...
plusHome-based self-collected vaginal specimens detect more cervical lesions and cancers than cytology
Hilden, Germany, and Gaithersburg, Md. (ots) - Vaginal self-collection for Hybrid Capture®-based HPV testing increases screening coverage and is more sensitive than Pap smear shows a Mexican study published today online in the Lancet Promising findings published today online in the Lancet[i] from a community- based, randomized equivalence trial undertaken by public ...
plusEuropean Renal Association - European Dialysis and Transplant Association (ERA-EDTA)
ERA-EDTA congress 2011: Late Breaking Clinical Trials I / RAVE study: In ANCA-associated vasculitis rituximab is just as effective and safe as standard therapy
Prague, Czech Republic (ots) - The randomised, double-blind, placebo-controlled multi-centre study (abstract no. 2511) investigated the efficacy and safety of the monoclonal antibody rituximab (RTX) in 197 ANCA-associated vasculitis (AAV) patients. This study showed that in patients with severe AAV a single course ...
plusEuropean Renal Association - European Dialysis and Transplant Association (ERA-EDTA)
XLVIII ERA-EDTA Congress in Prague from 23 June to 26 June 2011
Prag (ots) - The congress of the ERA-EDTA (European Renal Association and European Dialysis and Transplant Association) is the biggest congress in Europe on nephrology and renal replacement therapy. You are cordially invited to attend this Congress. The Opening Press Conference will be held on Thursday 23rd June, 11 am (Corinthia Hotel). Topic: Can the high level of cardiovascular risk among the European population be ...
plus